Arrowstreet Capital Limited Partnership Invests $770,000 in Castle Biosciences, Inc. (NASDAQ:CSTL)

Arrowstreet Capital Limited Partnership purchased a new stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 28,903 shares of the company’s stock, valued at approximately $770,000. Other large investors have also recently […]